Lung cancer death rates by smoking status: comparison of the Three-Prefecture Cohort study in Japan to the Cancer Prevention Study II in the USA.
Cigarette smoking is an established risk factor for lung cancer. However, the magnitude of the relative risk (RR) on lung cancer mortality in relation to cigarette smoking is reported to be lower in Japan than in Western countries. We investigated whether this discrepancy could be explained by differences in the exposure to cigarettes smoked, by differences in sensitivity to smoking, or by differences in lung cancer mortality among non-smokers. We examined the 10-year follow-up data on 88,153 participants in a Japanese population-based prospective study conducted in three prefectures. Data used as a Western counterpart was retrieved from a published report of the US Cancer Prevention Study (CPS)-II. Although there was a significant increased risk of lung cancer death among current smokers compared with non-smokers, the observed RR in the Three-Prefecture Study were much lower than RR reported in the CPS-II. Lung cancer mortality of our Japanese sample was lower among current smokers and higher among non-smokers regardless of age and sex. Current smokers in our sample had initiated smoking at an older age and smoked fewer cigarettes per day for shorter durations than those in the CPS-II sample. The Poisson regression model (controlling for age, number of cigarettes smoked per day and duration of smoking) showed that male current smokers in our sample had a lower risk of lung cancer compared with those in the CPS-II sample (rate ratio 0.34 [95%CI 0.27-0.43]). These findings might explain why Japanese risks of lung cancer are lower than those observed in Western countries.
Marugame
Tomomi
T
Statistics and Cancer Control Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. tmarugam@gan2.res.ncc.go.jp
Sobue
Tomotaka
T
Satoh
Hiroshi
H
Komatsu
Shoko
S
Nishino
Yoshikazu
Y
Nakatsuka
Haruo
H
Nakayama
Tomio
T
Suzuki
Takaichiro
T
Takezaki
Toshiro
T
Tajima
Kazuo
K
Tominaga
Suketami
S
D000328:Adult; D015331:Cohort Studies; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D008175:Lung Neoplasms / Q000453:epidemiology* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects*; D016540:Smoking Cessation; D013997:Time Factors; D014481:United States / Q000453:epidemiology
Jpn J Clin Oncol. 2003 Feb;33(2):98-104
12629062
Jpn J Clin Oncol. 1986 Jun;16(2):117-21
3016376
JAMA. 2002 Mar 6;287(9):1132-41
11879110
J Toxicol Environ Health. 1997 Mar;50(4):307-64
9120872
J Natl Cancer Inst. 1997 Nov 5;89(21):1580-6
9362155
Lung Cancer. 1999 Sep;25(3):147-59
10512125
Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):890-4
12223434
Int J Cancer. 1995 Jan 17;60(2):190-3
7829214
Br J Cancer. 2001 May 4;84(9):1199-206
11336471
Nutr Cancer. 2003;45(2):160-7
12881009
Int J Cancer. 2002 May 10;99(2):245-51
11979440
N Engl J Med. 1998 May 28;338(22):1565-71
9603793
Ann Oncol. 2001 Oct;12(10):1341-51
11762803
Jpn Circ J. 2001 Oct;65(10):887-92
11665793
Cancer. 1991 Feb 1;67(3):746-63
1985768
Environ Health Perspect. 1995 Nov;103 Suppl 8:219-24
8741787
Jpn J Cancer Res. 1994 May;85(5):464-73
8014103
N Engl J Med. 1993 Dec 9;329(24):1753-9
8179653
Environ Health Perspect. 1990 Jul;87:19-26
2269225
BMJ. 1994 Oct 8;309(6959):901-11
7755693
Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1193-9
11700268
Jpn J Cancer Res. 2001 Dec;92(12):1259-69
11749690
Int J Cancer. 2003 Jun 10;105(2):249-54
12673687
J Epidemiol. 1997 Jun;7(2):99-105
9255031
Biochem Biophys Res Commun. 1999 Aug 11;261(3):658-60
10441482
J Epidemiol. 2000 Jan;10(1):7-15
10695255